Results 111 to 120 of about 50,819 (268)
ABSTRACT Myasthenia gravis (MG) associated with disseminated thymoma is often refractory to conventional treatments due to continuous autoantibody production. The optimal treatment strategy, particularly the combination of complement component 5 (C5) inhibitor, neonatal Fc receptor (FcRn) antagonist, and surgical resection in thymoma‐associated ...
Hiroyuki Takenaka +3 more
wiley +1 more source
Statin-associated weakness in myasthenia gravis: a case report
Introduction Myasthenia gravis is a commonly undiagnosed condition in the elderly. Statin medications can cause weakness and are linked to the development and deterioration of several autoimmune conditions, including myasthenia gravis.
Keogh Michael J +3 more
doaj +1 more source
Abstract Background Efgartigimod disrupts the recycling of pathogenic IgG autoantibodies and may represent a candidate therapy for autoimmune encephalitis. This real‐world study evaluated the clinical efficacy, safety, and impact of efgartigimod on brain inflammation.
Huanyu Meng +12 more
wiley +1 more source
Myasthenia gravis in dogs [PDF]
Myasthenia gravis är en sjukdom som drabbar den neuromuskulära överföringen. Den förekommer i två former: kongenital (medfödd) och förvärvad. Kongenital myasthenia gravis beror på en defekt i acetylkolinreceptorn (AChR), som orsakas av olika mutationer ...
Andersson, Petra
core +1 more source
Epilepsy and Myasthenia Gravis: A Case Series
The association between epilepsy and myasthenia gravis has rarely been reported, and when it has been reported, it has only been in a small case series.
Iñigo Oyarzun +5 more
doaj +1 more source
Abstract Background Non‐ambulatory tetraparesis or tetraplegia in cats may constitute a diagnostic challenge for general practitioners. Therefore, this study aimed to evaluate if clinical variables from signalment, history, clinical examination and basic ancillary tests are associated with underlying diagnoses in cats with non‐ambulatory tetraparesis ...
Guido Bertoldi, Steven De Decker
wiley +1 more source
A Pilot Study on Tocilizumab in Very-Late-Onset Myasthenia Gravis
Ting-Ting Yang,1,* Ze-Yi Wang,1,* Ze-Xin Fan,1 Bo-Yi Yuan,1 Lin Ma,1 Jian-Feng Lu,1 Pen-Ju Liu,1 Yang He,2 Guang-Zhi Liu1 1Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People’s Republic of China ...
Yang TT +8 more
core
Summary Patients with immune thrombocytopenia (ITP) exhibit substantial heterogeneity in treatment responses. Approximately 30%–50% of patients maintain remission after discontinuation of thrombopoietin receptor agonists (TPO‐RA), suggesting immunomodulatory effects beyond enhanced thrombopoiesis.
Vivianne S. Nelson +5 more
wiley +1 more source
Delayed diagnosis of distal myasthenia gravis: a case report
Introduction Myasthenia gravis, which initially presents with prominent distal muscle weakness, is rare and is referred to as distal myasthenia gravis.
M. L. Cao +7 more
doaj +1 more source

